Steve Pascolo und Rna - Info zur Person

(1 - 14 von 22

)

Germany’s CureVac gets €22M for RNA cancer treatment |...

sciencebusiness.net

CureVac GmbH, a spin-out from the University of Tübingen, said it has received €22 million in a second round of financing for clinical trials for its RNA...

LinkedIn: Steve Pascolo – Founder And CEO – spRNA | LinkedIn

Sehen Sie sich das Profil von Steve Pascolo auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. 6 Jobs sind im Profil von Steve Pascolo aufgelistet.

DNA Vaccines: Methods and Protocols - Google Books

books.google.lv

3 Vaccination With Messenger RNA Steve Pascolo Summary As an alternative to DNA-based vaccines, messenger RNA (mRNA)-based vaccines present ...

Innate Immune Cell Determinants of T Cell Immunity: From ...

books.google.lv

Conflict of Interest Statement: Steve Pascolo is the founder and CEO of Miescher Pharma GmbH, a company exploiting the immunostimulating potential of RNA.

RNA Vaccines von Thomas Kramps | ISBN | Fachbuch...

www.lehmanns.de

RNA Vaccines von Thomas Kramps, Knut Elbers ... Generation of Immunostimulating 130 nm Protamine-RNA Nanoparticles Marina Tusup and Steve Pascolo 10.

Program CIMT Annual Meeting Yumpu

www.yumpu.com

15:40-15:55 “Anti-tumor immunotherapy by direct injection of stabilized. messenger RNA”. Steve Pascolo, Tübingen, Germany. 15:55-16:15 Coffee Break ... › view

Wikipedia: Chlorek litu – Wikipedia, wolna encyklopedia

[dostęp ]. Skocz do góry ↑ Steve Pascolo: RNA-Based Therapies. W: Shayne Cox Gad: Drug Discovery Handbook. John Wiley & Sons, Inc., 2005, s.

Rab27a regulates phagosomal pH and NADPH oxidase recruitment to...

www.nature.com

To prevent excessive degradation of internalized antigens, which could destroy the peptides recognized by T lymphocytes, dendritic cells have developed several...

Steve Pascolo - Patent applications

www.patentsencyclopedia.com

Steve Pascolo, Tuebingen DE. Patent application number, Description, Published , TRANSFECTION OF BLOOD CELLS WITH MRNA FOR ...

Steve Pascolo, Tubingen DE - Patent applications

www.patentsencyclopedia.com

Patent application number, Description, Published , Injection Solution for Rna - The invention relates to the use of RNA and an aqueous injection ...

Friday - BC2 Conference

www.bc2.ch

... with DeepBlue", (11:30-12:00) H6 Steve Pascolo (spRNA GmbH, Zurich), "The funding and development of biotechnology companies with different structures".